Why is big Pharma getting out of antibacterial drug discovery?-Reference-Cited by-同舟云学术

Why is big Pharma getting out of antibacterial drug discovery?

Published:2003-10 Issue:5 Volume:6 Page:427-430
ISSN:1369-5274
Container-title:Current Opinion in Microbiology
language:en
Short-container-title:Current Opinion in Microbiology

Author:

Projan Steven J

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Microbiology

Reference10 articles.

1. Infectious diseases: considerations for the 21st century;Fauci;Clin. Infect Dis.,2001

2. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae;Ahmad;Clin. Infect. Dis.,1999

3. Colistin: an antimicrobial for the 21st century?;Stein;Clin. Infect. Dis.,2002

4. US Food and Drug Administration. Labeling requirements for systematic antibacterial drug products intended for human use. 21 CFR Part 201 Docket No. 00N-1463. 2003.

5. Washington DC, anthrax response team. Inhalational anthrax outbreak among postal workers, Washington DC, 2001;Dewan;Emerg. Infect. Dis.,2002

Cited by 404 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of AMPs from random peptides via deep learning-based model and biological activity validation;European Journal of Medicinal Chemistry;2024-11

2. The demise of the antibiotic pipeline: the Bayer case;Humanities and Social Sciences Communications;2024-08-22

3. In Vitro and In Vivo Studies on a Mononuclear Ruthenium Complex Reveals It is a Highly Effective, Fast-Acting, Broad-Spectrum Antimicrobial in Physiologically Relevant Conditions;ACS Infectious Diseases;2024-08-06

4. Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem;Humanities and Social Sciences Communications;2024-07-20

5. The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials;Computers in Biology and Medicine;2024-02